Mayo Clinic researchers have identified a targeted therapy that could bring relief to people living with lichen planus, a ...

Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...

Diffuse midline gliomas (DMGs) are some of the most aggressive and deadly childhood brain tumors. These cancers, which mainly ...

Merck seems to have identified cytokines as a fertile ground for exploration, as the Synthekine deal follows its earlier $1.9 billion takeover of Pandion Therapeutics, which is developing a ...

offering a range of GMP-grade cytokines including IL-2, IL-7, IL-12, IL-15, IL-21, and others for use in CAR-T and CAR-NK cell therapy development. Learn more about the full list of GMP-grade ...

The most frequent of these immune-mediated toxicities are cytokine release syndrome (CRS ... used to manage CRS associated ...

Moreover, patients who had undergone prior CD19-directed CAR T-cell therapy had a complete response ... causing graft-versus-host disease, severe cytokine release syndrome, or immune effector ...

This sensitized other dendritic cells and macrophages in the tumor environment to topical imiquimod therapy, which inhibited the formation of new blood vessels via the cytokine IL12 leading to the ...